Vertex Pharmaceuticals Incorporated Stock
Equities
VRTX
US92532F1003
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
394.3 USD | +0.20% | -0.57% | -3.10% |
Apr. 18 | Vertex Pharmaceuticals Says FDA Granted Rolling Review of Suzetrigine to Treat Acute Pain | MT |
Apr. 17 | UBS Adjusts Vertex Pharmaceuticals Price Target to $466 From $498, Maintains Buy Rating | MT |
Financials (USD)
Sales 2024 * | 10.72B | Sales 2025 * | 11.74B | Capitalization | 102B |
---|---|---|---|---|---|
Net income 2024 * | 3.86B | Net income 2025 * | 4.44B | EV / Sales 2024 * | 7.91 x |
Net cash position 2024 * | 16.91B | Net cash position 2025 * | 21.28B | EV / Sales 2025 * | 6.85 x |
P/E ratio 2024 * |
26.4
x | P/E ratio 2025 * |
23
x | Employees | 5,400 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.89% |
Latest transcript on Vertex Pharmaceuticals Incorporated
1 day | +0.26% | ||
1 week | -1.69% | ||
Current month | -5.87% | ||
1 month | -4.35% | ||
3 months | -9.12% | ||
6 months | +7.05% | ||
Current year | -3.30% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 17-01-31 | |
Jeffrey Leiden
CHM | Chairman | 68 | 09-07-07 |
Charles Wagner
DFI | Director of Finance/CFO | 55 | 19-04-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Garber
BRD | Director/Board Member | 68 | 17-06-07 |
Jeffrey Leiden
CHM | Chairman | 68 | 09-07-07 |
Bruce Sachs
BRD | Director/Board Member | 64 | 97-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.67% | 0 M€ | 0.00% | - | |
7.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 394.3 | +0.20% | 1 323 803 |
24-04-18 | 393.5 | +0.10% | 949,091 |
24-04-17 | 393.1 | -0.27% | 881,020 |
24-04-16 | 394.2 | -0.80% | 695,469 |
24-04-15 | 397.4 | +0.20% | 1,373,702 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.30% | 102B | |
+1.79% | 96.07B | |
-1.57% | 21.66B | |
-18.35% | 20.77B | |
-7.77% | 18.53B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B | |
-21.69% | 8.57B |
- Stock Market
- Equities
- VRTX Stock